Hormel
HRL
$0.00
+0.76%
Hormel Foods Corporation is a leading branded food company operating in the Consumer Defensive sector, primarily within the Packaged Foods industry. Historically focused on meat, the company has broadened its portfolio to include a diverse range of protein offerings and shelf-stable products, with major brands like Hormel, Spam, Jennie-O, and Planters that often hold number one or two market share positions. The current investor narrative centers on a strategic pivot away from volatile commodity businesses, as evidenced by the recent divestiture of its whole-bird turkey unit, and navigating a challenging input cost environment marked by record beef prices, all while aiming to deliver steadier growth and protect its reliable dividend reputation.…
HRL
Hormel
$0.00
Related headlines
HRL 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Hormel's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
4 analysts
Implied Upside
—
vs. current price
Analyst Count
4
covering this stock
Price Range
$0 - $0
Analyst target range
Analyst coverage is limited, with only 4 analysts providing estimates, indicating this is a less-followed name which can lead to higher volatility and less efficient price discovery. The available data shows estimated EPS for the coming period has a tight range from $1.59 to $1.71, with an average of $1.65, and revenue estimates are clustered around $12.81 billion, suggesting analysts have a firm but narrow view on near-term fundamentals. Institutional ratings from recent months show a mix of 'Neutral' and 'Overweight' stances, with firms like Stephens & Co. maintaining 'Equal Weight', Barclays and JP Morgan at 'Overweight', and B of A Securities and Piper Sandler at 'Neutral', reflecting a cautious but not bearish consensus. The lack of a published consensus price target in the data, coupled with the low analyst count, implies that while professional sentiment is not overtly negative, there is limited conviction to drive a significant rerating, leaving the stock's fate largely tied to execution on its strategic shift and commodity cost management.
Bulls vs Bears: HRL Investment Factors
The evidence currently tilts bearish, as fundamental headwinds—specifically margin compression and earnings volatility—are concrete and severe, outweighing the potential value signaled by oversold technicals and a strong dividend. The most critical tension in the investment debate is whether the company's strategic pivot and cost management can successfully restore margin stability and predictable earnings growth before investor patience and the dividend's sustainability are further tested. If management fails to demonstrate a credible path to margin recovery in the next few quarters, the bear case of continued multiple compression will prevail.
Bullish
- Strong Free Cash Flow Supports Dividend: HRL generates robust trailing twelve-month free cash flow of $577.5 million, translating to a 4.4% FCF yield at the current price. This provides a solid foundation for its 4.85% dividend yield, a key attraction for income investors, especially as the payout ratio of 1.32 indicates the dividend is currently covered by cash generation, not just earnings.
- Deeply Oversold Technicals Near 52-Week Low: Trading at $21.08, the stock is just 17.8% above its 52-week low of $19.70, indicating extreme oversold conditions. With a 1-year decline of -28.35% and a 3-month drop of -15.65%, the stock's low beta of 0.313 suggests the sell-off is company-specific, potentially creating a value opportunity if fundamentals stabilize.
- Strategic Pivot to Higher-Margin Businesses: The recent divestiture of its volatile whole-bird turkey unit signals a strategic shift away from commodity exposure towards steadier, value-added protein products. This move, if successful, could lead to improved margin stability and reduce earnings volatility, which has been a major headwind.
- Attractive Forward Valuation on Recovery: The forward PE of 13.51x is a significant discount to the trailing PE of 27.31x, implying the market expects a substantial earnings recovery. If the company meets the average analyst EPS estimate of $1.65, the stock would be valued at a reasonable multiple compared to sector peers, offering potential upside.
Bearish
- Severe Margin Compression and Earnings Volatility: Gross margin has compressed from 16.71% in Q2 2025 to 15.51% in Q1 2026, reflecting intense input cost inflation. This pressure culminated in a Q4 2025 net loss of -$56.1 million, demonstrating extreme earnings volatility that undermines the stock's traditional defensive profile.
- Anemic and Inconsistent Revenue Growth: Revenue growth is stagnant, with Q1 2026 sales of $3.03 billion up only 1.29% year-over-year. The company remains heavily reliant on the US Retail segment (61.6% of sales), showing limited growth drivers and an inability to expand its top line meaningfully in a challenging environment.
- Elevated Trailing PE Despite Poor Performance: A trailing PE of 27.31x is high for a company with minimal growth and margin pressure, trading at a premium to typical packaged food peers. This valuation disconnect suggests the stock has not fully priced in the fundamental deterioration, leaving room for further multiple compression.
- Limited Analyst Coverage and Conviction: With only 4 analysts providing estimates and no published consensus price target, HRL suffers from low visibility and inefficient price discovery. The mix of 'Neutral' and 'Overweight' ratings reflects a lack of strong conviction needed to drive a sustained rerating.
HRL Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -28.35% and a 6-month decline of -7.10%. Trading at a current price of $21.08, it sits just above its 52-week low of $19.70, positioning it at only 17.8% of its 52-week range ($19.70 to $31.86), which signals deep oversold territory and potential value opportunity, though it also reflects significant fundamental and sentiment headwinds. Recent momentum shows continued weakness, with a 1-month decline of -0.80% and a 3-month drop of -15.65%, both of which align with and reinforce the longer-term downtrend, indicating no meaningful signs of a reversal or bottoming process yet. Key technical support is clearly defined at the 52-week low of $19.70, while resistance is far above at the 52-week high of $31.86; a breakdown below $19.70 would signal a new phase of weakness, whereas any sustained move above it could suggest stabilization. The stock's beta of 0.313 indicates it is approximately 69% less volatile than the broader market (SPY), which has gained 27.43% over the past year, highlighting HRL's severe underperformance and defensive, low-volatility characteristics that have failed to provide a safe haven during this sell-off.
Beta
0.31
0.31x market volatility
Max Drawdown
-37.4%
Largest decline past year
52-Week Range
$20-$32
Price range past year
Annual Return
-27.9%
Cumulative gain past year
| Period | HRL Return | S&P 500 |
|---|---|---|
| 1m | -0.9% | +4.4% |
| 3m | -15.0% | +8.5% |
| 6m | -6.4% | +9.7% |
| 1y | -27.9% | +28.8% |
| ytd | -9.2% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HRL Fundamental Analysis
Revenue growth is anemic and inconsistent, with the most recent Q1 2026 revenue of $3.03 billion representing a modest 1.29% year-over-year increase, but this follows a volatile pattern including a prior quarter (Q4 2025) where revenue was higher at $3.19 billion but profitability collapsed. Segment data for the latest period shows the Retail Segment driving the majority of sales at $1.85 billion, with Foodservice at $998 million and International at $181 million, indicating the company remains heavily reliant on the US consumer. The company is profitable but margins are under significant pressure; Q1 2026 net income was $181.8 million with a net margin of 6.00%, but this followed a disastrous Q4 2025 net loss of -$56.1 million due to high other expenses. Gross margin for Q1 2026 was 15.51%, which is low for a branded food company and has compressed from 16.71% in Q2 2025, reflecting intense input cost inflation and an unfavorable sales mix. The balance sheet and cash flow position remain a relative strength, with a solid current ratio of 2.47, a manageable debt-to-equity ratio of 0.36, and robust trailing twelve-month free cash flow of $577.5 million. This strong FCF, which supports the dividend, yields a FCF yield of approximately 4.4% based on the current market cap, indicating the company generates sufficient internal cash to fund operations and shareholder returns despite earnings volatility.
Quarterly Revenue
$3.0B
2026-01
Revenue YoY Growth
+0.01%
YoY Comparison
Gross Margin
+0.15%
Latest Quarter
Free Cash Flow
$577532000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HRL Overvalued?
Given the company's positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE is elevated at 27.31x, while the forward PE is significantly lower at 13.51x; this wide gap implies the market expects a substantial recovery in earnings over the next twelve months, likely pricing in a normalization from the recent quarterly loss. Compared to sector averages, HRL's trailing PE of 27.31x trades at a premium to the typical packaged foods industry average (often in the low 20s), but its forward PE of 13.51x would represent a discount if earnings estimates are met, suggesting the current price embeds skepticism about that recovery. Historically, the stock's own valuation has compressed dramatically; its current trailing PE of 27.31x is below the 34.32x seen in Q3 2023 but above the -58.20x from the loss-making Q4 2025. More tellingly, the price-to-sales ratio of 1.08 is near the bottom of its multi-year range, indicating the market is valuing its revenue base at a significant discount compared to past years, which could signal a value opportunity if fundamentals stabilize.
PE
27.3x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -58x~36x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: HRL faces significant margin pressure, with gross margin compressing 120 basis points from 16.71% to 15.51% over recent quarters, directly threatening profitability in a high-input-cost environment. Earnings volatility is extreme, as evidenced by the swing from a Q4 2025 net loss of -$56.1 million to Q1 2026 net income of $181.8 million, creating uncertainty for investors. While the dividend appears supported by strong free cash flow ($577.5M TTM), the payout ratio of 1.32 indicates it is not covered by current earnings, posing a risk if cash generation weakens.
Market & Competitive Risks: Valuation compression is a primary risk, as the stock's trailing PE of 27.31x remains elevated despite poor performance, trading at a premium to sector averages. If the expected earnings recovery (forward PE 13.51x) fails to materialize, the multiple could contract sharply. The stock's severe underperformance (relative strength of -55.78 vs. SPY over 1 year) despite its low beta of 0.313 indicates company-specific issues have overwhelmed its defensive characteristics, suggesting it may not serve as a safe haven. Recent news highlights a persistent macro risk: record beef prices driven by a historic cattle shortage create a multi-year headwind for meat processors' input costs.
Worst-Case Scenario: The worst-case involves a continuation of margin erosion, a failure of the strategic pivot to stabilize earnings, and a dividend cut if free cash flow deteriorates. This could trigger a loss of confidence among income-focused investors, the stock's core base. The realistic downside is a retest and break below the 52-week low of $19.70, which would represent a decline of approximately -6.5% from the current price. Given the stock's max drawdown of -37.41%, a more severe adverse scenario, perhaps driven by another quarterly loss, could see the stock fall towards the $17-$18 range, implying a potential loss of -15% to -20%.